US stocks starting with E
The official accounts of 132 companies listed in the United States whose name starts with E: revenue and net profit for the latest fiscal year, as stated in the annual report (Form 10-K) each one files with the SEC, in US dollars. Each one links to its page, with the document every figure comes from.
| Company | Ticker | Fiscal year | Revenue | Net profit |
|---|---|---|---|---|
| e.l.f. Beauty | NYSE: ELF | 2026 | $1,636m | $26.3m |
| E.W. Scripps | NASDAQ: SSP | 2025 | $2,151m | −$100.9m |
| Eagle Bancorp | NASDAQ: EGBN | 2025 | $299.2m | −$138.1m |
| Eagle Bancorp Montana | NASDAQ: EBMT | 2025 | $91.6m | $14.8m |
| Eagle Financial Services | NASDAQ: EFSI | 2025 | $69.5m | $8.2m |
| Eagle Materials | NYSE: EXP | 2026 | $2,309m | $423.8m |
| East West Bancorp | NASDAQ: EWBC | 2025 | $2,932m | $1,325m |
| Easterly Government Properties | NYSE: DEA | 2025 | $336.1m | $13.0m |
| Eastern Bankshares | NASDAQ: EBC | 2025 | $722.6m | $88.2m |
| Eastgroup Properties | NYSE: EGP | 2025 | $721.3m | $257.5m |
| Eastman Chemical | NYSE: EMN | 2025 | $8,752m | $474.0m |
| Eastman Kodak | NYSE: KODK | 2025 | $1,069m | −$128.0m |
| Eaton | NYSE: ETN | 2025 | $27,448m | $4,087m |
| eBay | NASDAQ: EBAY | 2025 | $11,100m | $2,031m |
| ECB Bancorp | NASDAQ: ECBK | 2025 | $33.2m | $7.8m |
| EchoStar | NASDAQ: ECHO | 2025 | $15,005m | −$14,497m |
| Ecolab | NYSE: ECL | 2025 | $16,081m | $2,076m |
| Ecopetrol | NYSE: EC | 2025 | COP 119,694,000m | COP 10,488,000m |
| Ecovyst | NYSE: ECVT | 2025 | $723.5m | −$71.1m |
| Edenor | NYSE: EDN | 2025 | ARS 2,990,891m | ARS 240,380m |
| Edgewell Personal Care | NYSE: EPC | 2025 | $2,224m | $25.4m |
| Edgewise Therapeutics | NASDAQ: EWTX | 2025 | — | −$167.8m |
| Edison International | NYSE: EIX | 2025 | $19,317m | $4,459m |
| Editas Medicine | NASDAQ: EDIT | 2025 | $40.5m | −$160.1m |
| Edwards Lifesciences | NYSE: EW | 2025 | $6,068m | $1,074m |
| eGain | NASDAQ: EGAN | 2026 | $91.1m | $8.9m |
| EL Pollo LOCO | NASDAQ: LOCO | 2025 | $490.0m | $26.5m |
| Elanco Animal Health | NYSE: ELAN | 2025 | $4,715m | −$232.0m |
| Elastic | NYSE: ESTC | 2026 | $1,739m | $367.8m |
| Electromed | NYSE: ELMD | 2026 | $73.8m | $11.3m |
| Eledon Pharmaceuticals | NASDAQ: ELDN | 2025 | — | −$45.6m |
| Element Solutions | NYSE: ESI | 2025 | $2,551m | $190.8m |
| Elevance Health | NYSE: ELV | 2025 | $199,125m | $5,662m |
| Eli Lilly | NYSE: LLY | 2025 | $65,179m | $20,640m |
| Elicio Therapeutics | NASDAQ: ELTX | 2025 | — | −$39.6m |
| Ellington Financial | NYSE: EFC | 2025 | $336.4m | $118.7m |
| Embecta | NASDAQ: EMBC | 2025 | $1,080m | $95.4m |
| Emcor | NYSE: EME | 2025 | $16,986m | $1,273m |
| Emergent Biosolutions | NYSE: EBS | 2025 | $742.9m | $52.6m |
| Emerson Electric | NYSE: EMR | 2026 | $18,982m | $2,691m |
| Empire State Realty OP | NYSE: ESBA | 2025 | $768.3m | $73.0m |
| Empire State Realty Trust | NYSE: ESRT | 2025 | $768.3m | $73.0m |
| Employers | NYSE: EIG | 2025 | $858.7m | $10.8m |
| Enact | NASDAQ: ACT | 2025 | $1,236m | $674.2m |
| Enanta Pharmaceuticals | NASDAQ: ENTA | 2025 | $65.3m | −$81.9m |
| Encompass Health | NYSE: EHC | 2025 | $5,935m | $566.2m |
| Encore Capital Group | NASDAQ: ECPG | 2025 | $1,769m | $256.8m |
| Encore Energy | NASDAQ: EU | 2025 | $43.2m | −$56.9m |
| Energizer | NYSE: ENR | 2025 | $2,953m | $239.0m |
| Energous | NASDAQ: WATT | 2025 | $5.6m | −$9.6m |
| Energy Fuels | NYSE: UUUU | 2025 | $65.9m | −$85.6m |
| Energy Recovery | NASDAQ: ERII | 2025 | $135.0m | $23.0m |
| Energy Transfer | NYSE: ET | 2025 | $85,536m | $4,433m |
| Energy Vault | NYSE: NRGV | 2025 | $203.7m | −$103.6m |
| Enerpac Tool Group | NYSE: EPAC | 2026 | $652.3m | $89.7m |
| EnerSys | NYSE: ENS | 2026 | $3,751m | $293.6m |
| Enliven Therapeutics | NASDAQ: ELVN | 2025 | — | −$103.7m |
| Ennis | NYSE: EBF | 2026 | $392.4m | $42.6m |
| Enova International | NYSE: ENVA | 2025 | $3,152m | $308.4m |
| Enovis | NYSE: ENOV | 2025 | $2,248m | −$1,184m |
| Enovix | NASDAQ: ENVX | 2025 | $31.8m | −$156.7m |
| Enphase Energy | NASDAQ: ENPH | 2025 | $1,473m | $172.1m |
| Enpro | NYSE: NPO | 2025 | $1,143m | $40.5m |
| Ensign Group | NASDAQ: ENSG | 2025 | $5,058m | $344.0m |
| Entegris | NASDAQ: ENTG | 2025 | $3,197m | $235.6m |
| Entergy | NYSE: ETR | 2025 | $12,947m | $1,773m |
| Enterprise Financial Services | NASDAQ: EFSC | 2025 | $739.9m | $201.4m |
| Enterprise Products Partners | NYSE: EPD | 2025 | $52,596m | $5,810m |
| Entrada Therapeutics | NASDAQ: TRDA | 2025 | $25.4m | −$143.8m |
| Entravision Communications | NYSE: EVC | 2025 | $447.6m | −$79.2m |
| Envela | NYSE: ELA | 2025 | $241.0m | $14.6m |
| Envista | NYSE: NVST | 2025 | $2,720m | $47.0m |
| EOG Resources | NYSE: EOG | 2025 | $22,632m | $4,980m |
| EOS Energy Enterprises | NASDAQ: EOSE | 2025 | $114.2m | −$969.6m |
| EPAM Systems | NYSE: EPAM | 2025 | $5,457m | $377.7m |
| ePlus | NASDAQ: PLUS | 2026 | $2,443m | $132.6m |
| EPR Properties | NYSE: EPR | 2025 | $718.4m | $274.9m |
| Epsilon Energy | NASDAQ: EPSN | 2025 | $51.6m | −$5.8m |
| EQT Corporation | NYSE: EQT | 2025 | $8,644m | $2,039m |
| Equifax | NYSE: EFX | 2025 | $6,075m | $660.3m |
| Equinix | NASDAQ: EQIX | 2025 | $9,217m | $1,350m |
| Equitable | NYSE: EQH | 2025 | $11,665m | −$1,380m |
| Equity Bancshares | NYSE: EQBK | 2025 | $210.1m | $22.7m |
| Equity Lifestyle Properties | NYSE: ELS | 2025 | $1,531m | $402.1m |
| Erasca | NASDAQ: ERAS | 2025 | — | −$124.5m |
| Erie Indemnity | NASDAQ: ERIE | 2025 | $4,067m | $559.3m |
| ESAB | NYSE: ESAB | 2025 | $2,843m | $226.8m |
| Escalade | NASDAQ: ESCA | 2025 | $240.2m | $13.7m |
| Esco Technologies | NYSE: ESE | 2025 | $1,095m | $299.2m |
| Espey MFG. & Electronics | NYSE: ESP | 2026 | $46.1m | $11.2m |
| Esquire Financial | NASDAQ: ESQ | 2025 | $146.6m | $50.8m |
| Essent Group | NYSE: ESNT | 2025 | $1,261m | $690.0m |
| Essential Properties Realty Trust | NYSE: EPRT | 2025 | $561.2m | $253.0m |
| Essential Utilities | NYSE: WTRG | 2025 | $2,475m | $616.4m |
| Essex Property Trust | NYSE: ESS | 2025 | $1,887m | $702.8m |
| Establishment Labs | NASDAQ: ESTA | 2025 | $211.1m | −$51.1m |
| Estée Lauder | NYSE: EL | 2026 | $15,049m | $182.0m |
| Ethan Allen Interiors | NYSE: ETD | 2026 | $579.5m | $39.9m |
| ETON Pharmaceuticals | NASDAQ: ETON | 2025 | $80.0m | −$4.6m |
| ETSY | NYSE: ETSY | 2025 | $2,884m | $163.0m |
| Euronet Worldwide | NASDAQ: EEFT | 2025 | $4,244m | $309.5m |
| EVE | NYSE: EVEX | 2025 | — | −$224.3m |
| EverCommerce | NASDAQ: EVCM | 2025 | $588.9m | $17.6m |
| Evercore | NYSE: EVR | 2025 | $3,880m | $591.9m |
| Everest Group | NYSE: EG | 2025 | $17,496m | $1,591m |
| Everforth | NYSE: EFOR | 2025 | $3,980m | $113.5m |
| Evergy | NASDAQ: EVRG | 2025 | $5,962m | $855.6m |
| Everpure | NYSE: P | 2026 | $3,663m | $188.2m |
| EverQuote | NASDAQ: EVER | 2025 | $692.5m | $99.3m |
| Eversource Energy | NYSE: ES | 2025 | $13,547m | $1,700m |
| Everspin Technologies | NASDAQ: MRAM | 2025 | $55.2m | −$0.6m |
| Evertec | NYSE: EVTC | 2025 | $931.8m | $141.6m |
| Everus Construction Group | NYSE: ECG | 2025 | $3,746m | $201.8m |
| EVgo | NASDAQ: EVGO | 2025 | $384.1m | −$41.6m |
| EVI Industries | NYSE: EVI | 2026 | $446.6m | $7.7m |
| Evolent Health | NYSE: EVH | 2025 | $1,876m | −$534.5m |
| Evolus | NASDAQ: EOLS | 2025 | $297.2m | −$51.6m |
| Evolution Petroleum | NYSE: EPM | 2026 | $86.3m | −$2.4m |
| Evolv Technologies | NASDAQ: EVLV | 2025 | $145.9m | −$33.1m |
| Excelerate Energy | NYSE: EE | 2025 | $1,228m | $39.2m |
| Exelixis | NASDAQ: EXEL | 2025 | $2,320m | $782.6m |
| Exelon | NASDAQ: EXC | 2025 | $24,258m | $2,768m |
| ExlService | NASDAQ: EXLS | 2025 | $2,088m | $251.0m |
| Expand Energy | NASDAQ: EXE | 2025 | $12,124m | $1,819m |
| Expedia Group | NASDAQ: EXPE | 2025 | $14,733m | $1,294m |
| Expeditors International | NYSE: EXPD | 2025 | $11,069m | $810.3m |
| Exponent | NASDAQ: EXPO | 2025 | $582.0m | $106.0m |
| Extra Space Storage | NYSE: EXR | 2025 | $3,378m | $974.0m |
| Extreme Networks | NASDAQ: EXTR | 2026 | $1,284m | $42.1m |
| ExxonMobil | NYSE: XOM | 2025 | $332,238m | $28,844m |
| EyePoint | NASDAQ: EYPT | 2025 | $31.4m | −$232.0m |
| Ezcorp | NASDAQ: EZPW | 2025 | $1,274m | $109.6m |
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell.